EPMA Journal
SCOPUS (2010-2025)SCIE-ISI
1878-5085
1878-5077
Cơ quản chủ quản: BioMed Central Ltd. , SPRINGER INT PUBL AG
Lĩnh vực:
Drug DiscoveryHealth PolicyBiochemistry (medical)
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Emerging issues in public health: a perspective on Ghana’s healthcare expenditure, policies and outcomes
- 2017
Abstract Ghana’s healthcare expenditure has increased over the past two decades.
Increased healthcare expenditures are required to enhance the acquisition of
better hospital resources that may improve healthcare. This study presents an
overview of healthcare expenditures and health outcomes (i.e. infant mortality,
under-5 mortality and life expectancy) from 1995 to 2014 in Ghana. Infant and
under-...
Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation
Abstract Proliferative diabetic retinopathy (PDR) the sequel of diabetic
retinopathy (DR), a frequent complication of diabetes mellitus (DM), is the
leading cause of blindness in the working-age population. The current screening
process for the DR risk is not sufficiently effective such that often the
disease is undetected until irreversible damage occurs. Diabetes-associated
small vessel disease ...
Biobanks in Horizon 2020: sustainability and attractive perspectives
Tập 9 Số 4 - Trang 345-353 - 2018
Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720
- 2014
Abstract Background The most commonly used biomarkers to predict the response of
breast cancer patients to therapy are the oestrogen receptor (ER), progesterone
receptor (PgR), and human epidermal growth factor receptor 2 (HER2). Patients
positive for these biomarkers are eligible for specific therapies such as
endocrine treatment in the event of ER and PgR positivity, and the monoclonal
antibody,...